Posttransplant lymphoproliferative disorder: incidence, presentation, and response to treatment in lung transplant recipients.
about
Therapeutic options in post-transplant lymphoproliferative disorders.Pulmonary complications of solid organ and hematopoietic stem cell transplantation.Management of patients with post-transplant lymphoproliferative disorder: the role of rituximab.Critical care perspective on immunotherapy in lung transplantation.Posttransplant lymphoproliferative disease after lung transplantation.Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelinesPresentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation.Post-transplant lymphoproliferative disorders in lung transplant recipients: 20-yr experience at the University of Minnesota.Pulmonary arterial hypertension and lung transplantation.Managing post-transplant lymphoproliferative disorders in solid-organ transplant recipients: a review of immunosuppressant regimens.Pulmonary nodules and masses in lung transplant recipients: clinical and CT findings.Post-transplant lymphoproliferative disorders with naso- and oropharyngeal manifestation.Endobronchial Epstein-Barr Virus Associated Post-transplant Lymphoproliferative Disorder in Hematopoietic Stem Cell Transplantation.Use of Foscarnet Therapy for EBV Infection following Control of PTLD with Enhancement of Cellular Immunity in a Lung-Transplant Recipient.Retransplantation after post-transplant lymphoproliferative disorders: an OPTN/UNOS database analysis.Allograft involvement by lymphoproliferative disorders after lung transplantation: report from the PTLD. Int survey.CD20 expression predicts survival in paediatric post-transplant lymphoproliferative disease (PTLD) following solid organ transplantation.OKT3 and ganciclovir treatments are possibly related to the presence of Epstein-Barr virus in serum after liver transplantation.Functional status and quality of life in patients surviving 10 years after lung transplantation.Native lung pneumonectomy for post-transplantation lymphoproliferative disorder refractory to rituximab following contralateral lung transplantation.Post-transplant Lymphoproliferative Disorders: Determination of Donor/Recipient Origin in a Large Cohort of Kidney RecipientsIs vaccine therapy the future in cancer prevention?Radiological findings of complications after lung transplantationPost-transplant lymphoproliferative disorder presenting on post-transplant Day 35 as a pulmonary parenchymal infiltrate-a case report
P2860
Q30455714-89271D08-3FCA-4BAF-90BD-EF6F693154E6Q35740698-BC8D6F53-8C67-4728-B6D2-D69AD7D19844Q36435819-63D7F9A8-2884-4F5B-A87A-2D20546DC126Q36649380-7CCE5148-86AD-4EAE-B7D5-FF8579E62330Q36701511-2A8AAE71-7B3D-46CF-B287-0EB889963357Q36724093-936FDAAE-035F-4000-BA59-FCB29721836AQ36732580-ACDEBBD3-3D25-4A7C-B5A6-282CB5C088D1Q37809559-D2FE027E-62EC-4F40-AEAD-2CC4F6D6F61DQ37894098-157735C4-CFC6-487B-A2BC-25AECEBDA8BAQ38032320-EECBEF5D-AB32-49E9-91A1-F056A54DBB2CQ38217460-2A28F32E-069D-4587-B472-33EC6E7EBBB7Q40765516-C4D6B539-A286-484C-BD71-A817B2CD19FBQ41908744-2979F83E-FC11-476E-ADC0-D231A1F89B7DQ41929024-9E920362-C18A-40D2-92DB-042FACA9D7FFQ42601070-DC543818-FD5B-4DF9-BB80-577F2978893BQ43559889-4A01DCDC-97C3-40BD-A6E8-4E7CF47125C4Q45279494-FE0EDE3C-9DA4-4E5C-9C2C-4CEC75E59FE2Q45450388-E3D31924-2419-460E-ACA1-2AD4915D9CEEQ47819035-A5AED86F-6D47-43D8-8C56-072DF5D49923Q51638039-9AA1CD63-5D48-41D9-80AA-E1A5B812564EQ56908074-63AD9396-4DC2-49D0-B16D-ABC788C59074Q56959463-243D643F-FFE4-4E2D-8AB4-DEB17E4FC962Q58775530-D306D874-8890-4814-A6CD-656F832A3F57Q58794516-00D33336-36E9-4944-B156-D8D3EFC3BC66
P2860
Posttransplant lymphoproliferative disorder: incidence, presentation, and response to treatment in lung transplant recipients.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Posttransplant lymphoprolifera ...... in lung transplant recipients.
@ast
Posttransplant lymphoprolifera ...... in lung transplant recipients.
@en
type
label
Posttransplant lymphoprolifera ...... in lung transplant recipients.
@ast
Posttransplant lymphoprolifera ...... in lung transplant recipients.
@en
prefLabel
Posttransplant lymphoprolifera ...... in lung transplant recipients.
@ast
Posttransplant lymphoprolifera ...... in lung transplant recipients.
@en
P2093
P356
P1433
P1476
Posttransplant lymphoprolifera ...... in lung transplant recipients.
@en
P2093
B Diane Reams
David N Howell
H Page McAdams
Mark P Steele
R Duane Davis
Scott M Palmer
P304
P356
10.1378/CHEST.124.4.1242
P407
P577
2003-10-01T00:00:00Z